Type VII secretion in Streptococcus gallolyticus adherence

溶没食子链球菌粘附中的 VII 型分泌

基本信息

  • 批准号:
    10593764
  • 负责人:
  • 金额:
    $ 18.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-11-14 至 2024-10-31
  • 项目状态:
    已结题

项目摘要

Streptococcus gallolyticus subsp. gallolyticus (Sgg) is a medically important gut pathobiont that causes life-threatening bacteremia and infective endocarditis (IE) and promotes colorectal cancer (CRC). However, the molecular mechanisms underlying Sgg pathogenicity remain poorly understood. The pathogenic process of Sgg (previously known as S. bovis biotype I) involves colonizing the colon, influencing the colonic epithelium homeostasis and barrier integrity, and disseminating from the gut to the circulatory system to cause bacteremia and IE. Our long-term goals are to understand how this organism colonizes the colon, how it affects gut epithelial homeostasis and integrity, and how to use the knowledge to mitigate Sgg-induced pathologies. This application will investigate a novel mechanism that mediates Sgg adherence to the colonic epithelium. Previous studies suggest that Sgg adherence to colonic epithelial cells facilitates gut colonization24,25, and is linked to its ability to promote cell proliferation13 and to translocate23. Thus, adherence to the colonic epithelium is a critical early step in the pathogenic process of Sgg, however, the current mechanistic understanding of Sgg adherence is limited. Additional adherence mechanisms remain to be elucidated to fill a major knowledge gap. The hypothesis of this proposal is that two components of a type VII secretion system (T7SS) of Sgg collaboratively mediate the adherence of Sgg to the colonic epithelium by targeting a specific host cell receptor. T7SS is a specialized secretion system known to mediate pathogen interactions with the host. It has been shown to be important for the virulence and persistence of other pathogens. The Xu lab recently reported the first functional characterization of a T7SS in Sgg strain TX20005 (T7SST05) and demonstrated that this T7SS is a pathogenicity determinant of Sgg. In particular, deletion of core components of the T7SST05 secretion machinery resulted in significantly reduced capacity to adhere to colonic epithelial cells and to colonize the colon in vivo. The objectives of this proposal are to define the role of the T7SST05 components in adherence to the colonic epithelium (Aim 1) and to determine the host cell surface receptor targeted by Sgg for adherence (Aim 2). Given the limited mechanistic understanding of Sgg pathogenicity, the proposed work will provide crucial breakthroughs in identifying novel molecular players that mediate Sgg colonization of the colonic epithelium, thereby fill a major knowledge gap. Furthermore, the specific Sgg factors identified in this work are candidates for diagnostic biomarkers and clinical intervention targets, and therefore have translational potential.
溶没食子链球菌亚种。溶没食子酸杆菌 (Sgg) 是一种医学上重要的肠道病原体,可导致 危及生命的菌血症和感染性心内膜炎(IE)并促进结直肠癌(CRC)。然而, Sgg 致病性的分子机制仍知之甚少。 Sgg的发病过程 (以前称为牛链球菌生物型 I)涉及在结肠定殖,影响结肠上皮 体内平衡和屏障完整性,并从肠道传播到循环系统导致菌血症 和IE。我们的长期目标是了解这种生物体如何在结肠中定殖,如何影响肠道上皮细胞 稳态和完整性,以及如何利用这些知识来减轻 Sgg 引起的病理。这个应用程序 将研究一种介导 Sgg 粘附到结肠上皮的新机制。 先前的研究表明,Sgg 粘附在结肠上皮细胞上有利于肠道定植24,25 和 与其促进细胞增殖13 和易位23 的能力有关。因此,坚持结肠 上皮细胞是 Sgg 致病过程中关键的早期步骤,然而,目前的机制 对 Sgg 依从性的了解是有限的。额外的依从机制仍有待阐明,以填补 主要知识差距。 该提议的假设是 Sgg VII 型分泌系统(T7SS)的两个组成部分 通过靶向特定的宿主细胞受体,协同介导 Sgg 与结肠上皮的粘附。 T7SS 是一种专门的分泌系统,已知可介导病原体与宿主的相互作用。已经显示了 对于其他病原体的毒力和持久性很重要。徐实验室最近报道了第一个 对 Sgg 菌株 TX20005 (T7SST05) 中的 T7SS 进行功能表征,并证明该 T7SS 是 Sgg 的致病性决定因素。特别是 T7SST05 分泌机制核心组件的删除 导致体内粘附结肠上皮细胞和定植结肠的能力显着降低。 该提案的目标是定义 T7SST05 组件在遵守结肠规则方面的作用 上皮细胞(目标 1)并确定 Sgg 粘附的宿主细胞表面受体(目标 2)。给定 由于对 Sgg 致病性的机制了解有限,拟议的工作将提供至关重要的 在鉴定介导 Sgg 结肠上皮定植的新型分子参与者方面取得了突破, 从而填补了一个重大的知识空白。此外,本工作中确定的具体 Sgg 因素是候选因素 用于诊断生物标志物和临床干预目标,因此具有转化潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YI XU其他文献

YI XU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YI XU', 18)}}的其他基金

Activation of TGFbeta by a gut pathobiont
肠道病原体激活 TGFbeta
  • 批准号:
    10113536
  • 财政年份:
    2020
  • 资助金额:
    $ 18.36万
  • 项目类别:
Manipulation of host complement by Clostridium difficile spores - an immune evasion strategy.
通过艰难梭菌孢子操纵宿主补体——一种免疫逃避策略。
  • 批准号:
    9091899
  • 财政年份:
    2016
  • 资助金额:
    $ 18.36万
  • 项目类别:
Manipulation of host complement by Clostridium difficile spores - an immune evasion strategy.
通过艰难梭菌孢子操纵宿主补体——一种免疫逃避策略。
  • 批准号:
    9208095
  • 财政年份:
    2016
  • 资助金额:
    $ 18.36万
  • 项目类别:
Bacillus Anthracis and Complement
炭疽杆菌和补体
  • 批准号:
    8522147
  • 财政年份:
    2012
  • 资助金额:
    $ 18.36万
  • 项目类别:
Bacillus Anthracis and Complement
炭疽杆菌和补体
  • 批准号:
    8373133
  • 财政年份:
    2012
  • 资助金额:
    $ 18.36万
  • 项目类别:
Bacillus Anthracis and Complement
炭疽杆菌和补体
  • 批准号:
    8699674
  • 财政年份:
    2012
  • 资助金额:
    $ 18.36万
  • 项目类别:
Bacillus Anthracis and Complement
炭疽杆菌和补体
  • 批准号:
    8889614
  • 财政年份:
    2012
  • 资助金额:
    $ 18.36万
  • 项目类别:
The Role of Lung Epithelium in B. anthracis Pathogenesis
肺上皮在炭疽杆菌发病机制中的作用
  • 批准号:
    7641898
  • 财政年份:
    2009
  • 资助金额:
    $ 18.36万
  • 项目类别:
The Role of Lung Epithelium in B. anthracis Pathogenesis
肺上皮在炭疽杆菌发病机制中的作用
  • 批准号:
    7942879
  • 财政年份:
    2009
  • 资助金额:
    $ 18.36万
  • 项目类别:
Molecular Regulation of Human iNOS by Phosphorylation
人 iNOS 磷酸化的分子调控
  • 批准号:
    6934576
  • 财政年份:
    2004
  • 资助金额:
    $ 18.36万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了